U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07537751) titled 'Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis' on April 12.
Brief Summary: This randomized, double-blind trial compared topical crisaborole 2% with topical fluticasone propionate 0.05% in children aged 1-12 years with mild to moderate atopic dermatitis. Forty patients were assigned to receive either crisaborole or fluticasone twice daily on affected areas for 6 weeks, with responders (>75% improvement in SCORAD) continuing the same treatment twice weekly for 12 weeks as maintenance. The study evaluated improvement in disease severity using SCORAD and ISGA, pruritus scores, disease-free survival, and lo...